RF Capital Group Inc. buy krebskrebs
Start price
29.06.20
/
50%
€8.05
Target price
04.11.21
€10.00
Performance (%)
77.64%
End price
05.11.21
€14.30
Summary
This prediction ended on 05.11.21 with a price of €14.30. The BUY prediction by krebskrebs for RF Capital Group Inc. saw massive gains of 77.64%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
RF Capital Group Inc. | 7.895% | 7.895% | 22.388% | -65.833% |
iShares Core DAX® | -1.958% | 4.037% | 23.702% | 22.534% |
iShares Nasdaq 100 | 0.272% | 8.670% | 28.181% | 41.859% |
iShares Nikkei 225® | 0.377% | 7.232% | 21.118% | 9.739% |
iShares S&P 500 | 0.370% | 6.511% | 29.221% | 41.850% |
Comments by krebskrebs for this prediction
In the thread RF Capital Group Inc. diskutieren
Buy mit Kursziel 1,0
In the thread Trading RF Capital Group Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten